Suppr超能文献

2000 年至 2006 年加拿大安大略省对青霉素敏感性降低的侵袭性脑膜炎奈瑟菌病的流行病学。

Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

机构信息

Ontario Agency for Health Protection and Promotion, Public Health Laboratories, 81 Resources Road, Toronto, Ontario, Canada M9P 3T1.

出版信息

Antimicrob Agents Chemother. 2010 Mar;54(3):1016-21. doi: 10.1128/AAC.01077-09. Epub 2010 Jan 19.

Abstract

Neisseria meningitidis has been relatively slow to acquire resistance to penicillin. We previously reported an increase in the incidence of invasive meningococcal disease (IMD) strains with decreased susceptibility to penicillin (DSP) in Ontario. Our objectives were to evaluate trends in IMD with DSP, to identify case-level predictors of IMD with DSP, and to evaluate the relationship among DSP, bacterial phenotype, and the likelihood of a fatal outcome. All IMD isolates received in Ontario between 2000 and 2006 were submitted to the Public Health Laboratories, Toronto, for confirmation of the species, serogroup determination, and susceptibility testing. Isolates were considered to be IMD strains with DSP if the penicillin MIC was > or =0.125 microg/ml. Temporal trends were evaluated using multivariable Poisson regression models. Correlates of diminished susceptibility and fatal outcome were evaluated with multivariable logistic regression models. The overall rate of IMD caused by strains with DSP in Ontario was approximately 1.20 cases per million population annually (95% confidence interval [95% CI], 0.99 to 1.46). Seventy-nine strains (21.7%) were IMD strains with DSP. There was no year-to-year trend in the incidence of IMD with DSP. IMD with DSP was strongly associated with strains of serogroups Y (odds ratio [OR], 6.3; 95% CI, 3.6 to 11.1) and W-135 (OR, 8.2; 95% CI, 4.0 to 16.7). Infection with serogroup B or C strains was associated with a marked increase in the risk of mortality (OR, 3.07; 95% CI, 1.39 to 6.75); however, no association between IMD with DSP and mortality was observed. In contrast to trends of the 1990s, the incidence of IMD with DSP was stable in Ontario between 2000 and 2006. In Ontario, the serogroup rather than the penicillin MIC is the microbiological parameter most predictive of mortality.

摘要

脑膜炎奈瑟菌对青霉素的耐药性相对较慢。我们之前报道过安大略省侵袭性脑膜炎球菌病(IMD)菌株对青霉素(DSP)的易感性降低的发病率增加。我们的目标是评估 DSP 侵袭性脑膜炎球菌病的趋势,确定 DSP 侵袭性脑膜炎球菌病的病例水平预测因子,并评估 DSP、细菌表型和致命结果之间的关系。2000 年至 2006 年间在安大略省收到的所有 IMD 分离株均提交给多伦多公共卫生实验室进行鉴定,以确定物种、血清群确定和药敏试验。如果青霉素 MIC 为 > = 0.125 mcg/ml,则分离株被认为是 IMD 菌株的 DSP。使用多变量泊松回归模型评估时间趋势。使用多变量逻辑回归模型评估易感性降低和致命结果的相关性。安大略省由 DSP 菌株引起的 IMD 的总体发生率约为每年每百万人口 1.20 例(95%置信区间[95%CI],0.99 至 1.46)。79 株(21.7%)是 IMD 菌株的 DSP。DSP 侵袭性脑膜炎球菌病的发病率没有逐年趋势。DSP 侵袭性脑膜炎球菌病与 Y 血清群(比值比[OR],6.3;95%CI,3.6 至 11.1)和 W-135(OR,8.2;95%CI,4.0 至 16.7)菌株密切相关。感染 B 或 C 血清群菌株与死亡率显著增加相关(OR,3.07;95%CI,1.39 至 6.75);然而,未观察到 DSP 侵袭性脑膜炎球菌病与死亡率之间的关联。与 20 世纪 90 年代的趋势相反,2000 年至 2006 年间安大略省 DSP 侵袭性脑膜炎球菌病的发病率保持稳定。在安大略省,血清群而不是青霉素 MIC 是预测死亡率的最重要的微生物学参数。

相似文献

1
Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.
Antimicrob Agents Chemother. 2010 Mar;54(3):1016-21. doi: 10.1128/AAC.01077-09. Epub 2010 Jan 19.
2
Australian Meningococcal Surveillance Programme annual report, 2015.
Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E503-E511.
3
Australian Meningococcal Surveillance Programme annual report, 2014.
Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E221-8.
4
Australian Meningococcal Surveillance Programme annual report, 2013.
Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E301-8.
5
Epidemiology and genetic diversity of invasive Neisseria meningitidis strains circulating in Portugal from 2003 to 2020.
Int Microbiol. 2024 Aug;27(4):1125-1136. doi: 10.1007/s10123-023-00463-w. Epub 2023 Dec 7.
6
Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
Vaccine. 2015 Oct 13;33(42):5678-5683. doi: 10.1016/j.vaccine.2015.08.023. Epub 2015 Aug 20.
7
Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016.
Clin Infect Dis. 2019 Jul 18;69(3):495-504. doi: 10.1093/cid/ciy914.
8
Australian Meningococcal Surveillance Programme annual report, 2019.
Commun Dis Intell (2018). 2020 Aug 17;44. doi: 10.33321/cdi.2020.44.62.
9
Australian Meningococcal Surveillance Programme annual report, 2016.
Commun Dis Intell Q Rep. 2017 Dec 1;41(4):E369-E382.
10
Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005.
J Clin Microbiol. 2008 Oct;46(10):3208-14. doi: 10.1128/JCM.00221-08. Epub 2008 Jul 23.

引用本文的文献

1
Global epidemiology of serogroup Y invasive meningococcal disease: a literature review.
Epidemiol Infect. 2024 Dec 5;152:e157. doi: 10.1017/S0950268824001535.
2
Susceptibilities of invasive strains to agents used for prophylaxis and to penicillin G.
J Assoc Med Microbiol Infect Dis Can. 2021 Dec 3;6(4):307-312. doi: 10.3138/jammi-2020-0034. eCollection 2021 Dec.
3
Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
J Infect Dis. 2022 Jun 1;225(11):1871-1875. doi: 10.1093/infdis/jiac046.
4
Antibiotic susceptibility and molecular analysis of invasive Neisseria meningitidis recovered in the Republic of Ireland, 1996 to 2016.
Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1127-1136. doi: 10.1007/s10096-020-04114-0. Epub 2021 Jan 5.
5
Epidemiological profile of in Casablanca, Morocco: 2010-2019.
Access Microbiol. 2020 Jul 22;2(9):acmi000157. doi: 10.1099/acmi.0.000157. eCollection 2020.
7
Neisseria meningitidis Antimicrobial Resistance in Italy, 2006 to 2016.
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00207-18. Print 2018 Sep.
8
Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009.
Open Forum Infect Dis. 2016 Jul 13;3(3):ofw152. doi: 10.1093/ofid/ofw152. eCollection 2016 Sep.
9
Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.
Open Forum Infect Dis. 2015 Aug 13;2(3):ofv117. doi: 10.1093/ofid/ofv117. eCollection 2015 Sep.

本文引用的文献

1
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.
N Engl J Med. 2009 Feb 26;360(9):886-92. doi: 10.1056/NEJMoa0806414.
2
Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005.
J Clin Microbiol. 2008 Oct;46(10):3208-14. doi: 10.1128/JCM.00221-08. Epub 2008 Jul 23.
3
Is there room for improving case management for contacts of meningococcal disease in the European Union?
Euro Surveill. 2008 Mar 6;13(10):8057. doi: 10.2807/ese.13.10.08057-en.
7
Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region.
Int J Antimicrob Agents. 2007 Jun;29(6):621-9. doi: 10.1016/j.ijantimicag.2006.11.031. Epub 2007 Mar 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验